BUZZ-Lepu Biopharma jumps most in 12 weeks on progress of cancer drug application

Reuters09-27

** Shares of Lepu Biopharma Co Ltd jump 9.8% to HK$3.47, on track for the biggest one-day pct rise since July 5

** Stock hit the highest since Aug. 5, extending gains for third consecutive session

** Lepu said China National Medical Products Administration issued an acceptance notice of the firm's application for drug candidate MRG003 to treat recurrent or metastatic nasopharyngeal cancer

** "In the future, the company will fully promote the commercialisation of MRG003, which will have a positive impact on the operating results and further enhance the competitiveness of the company" - Lepu

** Hang Seng Commerce & Industry Index surges 4.9%, healthcare index jumps 7.1% and Hang Seng Index rises 3.6%

** Stock down 24.9% YTD

(Reporting by Donny Kwok)

((donny.kwok@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment